Somatic mosaicism in FSHD often goes undetected

Annals of Neurology

Volumn 55, Issue 6, 2004, Pages 845-850

  Lemmers, Richard J L F ^a   Van Der Wielen, Michiel J R ^a   Bakker, Egbert ^a   Padberg, George W ^b   Frants, Rune R ^a   Van Der Maarel, Silvère M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 4Q; CLINICAL ARTICLE; DISEASE ASSOCIATION; ELECTROPHORESIS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENE MUTATION; HUMAN; MALE; MITOSIS; MOSAICISM; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING;

ADULT; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 4; DNA; ELECTROPHORESIS, GEL, PULSED-FIELD; FAMILY HEALTH; FEMALE; HAPLOTYPES; HUMANS; MALE; MOSAICISM; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PEDIGREE; PHENOTYPE; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 2542517804     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20106     Document Type: Article

References (26)

1. Padberg GW. Facioscapulohumeral disease. Thesis. Leiden University, The Netherlands, 1982.
2. Brouwer OF, Padberg GW, Ruys CJ, et al. Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 1991;41: 1878-1881.
3. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992;2:26-30.
4. van Deutekom JC, Wijmenga C, van Tienhoven EA, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-2042.
5. Tawil R, Forrester J, Griggs RC, et al. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 1996;39:744-748.
6. Lunt PW, Jardine PE, Koch MC, et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35- facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4:951-958.
7. Bakker E, Wijmenga C, Vossen RH, et al. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve 1995;2:39-44.
8. Deidda G, Cacurri S, Grisanti P, et al. Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet 1995;3:155-167.
9. Lemmers RJL, de Kievit P, van Geel M, et al. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 2001;50: 816-819.
10. Padberg GW, Frants RR, Brouwer OF, et al. Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 1995;2:S81-S84.
11. Zatz M, Marie SK, Passos Bueno MR, et al. High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy. Am J Hum Genet 1995;56:99-105.
12. Bakker E, van der Wielen MJ, Voorhoeve E, et al. Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases. J Med Genet 1996;33:29-35.
13. Upadhyaya M, Maynard J, Osborn M, et al. Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle Nerve 1995;2:45-49.
14. Kohler J, Rupilius B, Otto M, et al. Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis. Hum Genet 1996;98:485-490.
15. Zatz M, Marie SK, Cerqueira A, et al. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet 1998;77: 155-161.
16. Galluzzi G, Deidda G, Cacurri S, et al. Molecular analysis of 4q35 rearrangements in fascioscapulohumeral muscular dystrophy (FSHD): application to family studies for a correct genetic advice and a reliable prenatal diagnosis of the disease. Neuromuscul Disord 1999;9:190-198.
17. van der Maarel SM, Deidda G, Lemmers RJ, et al. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet 2000;66:26-35.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. den Dunnen JT, van Ommen GJ. Methods for pulsed-field gel electrophoresis. Appl Biochem Biotechnol 1993;38:161-177.
20. Neuweiler J, Ruvolo V, Baum H, et al. Isolation and characterization of a hypervariable region [D4S163] on chromosome 4. Nucleic Acids Res 1990;18:691.
21. Milner EC, Lotshaw CL, Willems vD, et al. Isolation and mapping of a polymorphic DNA sequence pH30 on chromosome 4. Nucleic Acids Res 1989;17:4002.
22. van Deutekom JC, Bakker E, Lemmers RJ, et al. Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet 1996;5: 1997-2003.
23. Orrell RW, Tawil R, Forrester J, et al. Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 1999; 52:1822-1826.
24. Lunt P. Facioscapulohumeral muscular dystrophy: diagnostic and molecular aspects. In: Deymeer F, ed. Neuromuscular diseases: from basic mechanisms to clinical management. Vol 18. Basel: Karger, 2000:44-60.
25. Lindblad K, Schalling M. Expanded repeat sequences and disease. Semin Neurol 1999;19:289-299.
26. Brooke MH. A clinician's view of neuromuscular diseases. 1st ed. Baltimore: Williams & Wilkins, 1977.